Literature DB >> 26613837

Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.

Brian R Englum1, Jennifer Rothman1, Sarah Leonard1, Audra Reiter1, Courtney Thornburg1, Mary Brindle2, Nicola Wright2, Matthew M Heeney3, C Jason Smithers3, Rebeccah L Brown4, Theodosia Kalfa4, Jacob C Langer5, Michaela Cada5, Keith T Oldham6, J Paul Scott6, Shawn D St Peter7, Mukta Sharma7, Andrew M Davidoff8, Kerri Nottage8, Kathryn Bernabe9, David B Wilson9, Sanjeev Dutta10, Bertil Glader10, Shelley E Crary11, Melvin S Dassinger11, Levette Dunbar12, Saleem Islam12, Manjusha Kumar13, Fred Rescorla13, Steve Bruch14, Andrew Campbell14, Mary Austin15, Robert Sidonio16, Martin L Blakely17, Henry E Rice1.   

Abstract

PURPOSE: The purpose of this study was to define the hematologic response to total splenectomy (TS) or partial splenectomy (PS) in children with hereditary spherocytosis (HS) or sickle cell disease (SCD).
METHODS: The Splenectomy in Congenital Hemolytic Anemia (SICHA) consortium registry collected hematologic outcomes of children with CHA undergoing TS or PS to 1 year after surgery. Using random effects mixed modeling, we evaluated the association of operative type with change in hemoglobin, reticulocyte counts, and bilirubin. We also compared laparoscopic to open splenectomy.
RESULTS: The analysis included 130 children, with 62.3% (n=81) undergoing TS. For children with HS, all hematologic measures improved after TS, including a 4.1g/dl increase in hemoglobin. Hematologic parameters also improved after PS, although the response was less robust (hemoglobin increase 2.4 g/dl, p<0.001). For children with SCD, there was no change in hemoglobin. Laparoscopy was not associated with differences in hematologic outcomes compared to open. TS and laparoscopy were associated with shorter length of stay.
CONCLUSION: Children with HS have an excellent hematologic response after TS or PS, although the hematologic response is more robust following TS. Children with SCD have smaller changes in their hematologic parameters. These data offer guidance to families and clinicians considering TS or PS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital hemolytic anemia; Hematologic outcomes; Splenectomy; Surgical technique

Mesh:

Substances:

Year:  2015        PMID: 26613837      PMCID: PMC5083068          DOI: 10.1016/j.jpedsurg.2015.10.028

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

1.  Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.

Authors:  Henry E Rice; Keith T Oldham; Cheryl A Hillery; Michael A Skinner; Sara M O'Hara; Russell E Ware
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

Review 2.  Comparative effectiveness of different types of splenectomy for children with congenital hemolytic anemias.

Authors:  Henry E Rice; Shelley E Crary; Jacob C Langer; Alex R Kemper
Journal:  J Pediatr       Date:  2011-11-03       Impact factor: 4.406

3.  Comparison of laparoscopic and open splenectomy in children with hematologic disorders.

Authors:  R A Farah; Z R Rogers; W R Thompson; B A Hicks; P C Guzzetta; G R Buchanan
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

4.  Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay.

Authors:  Trudie Goers; Julie Panepinto; Michael Debaun; Morey Blinder; Robert Foglia; Keith T Oldham; Joshua J Field
Journal:  Pediatr Blood Cancer       Date:  2008-03       Impact factor: 3.167

5.  Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis.

Authors:  B Bader-Meunier; F Gauthier; F Archambaud; T Cynober; F Miélot; J P Dommergues; J Warszawski; N Mohandas; G Tchernia
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

6.  Risk of infection and death among post-splenectomy patients.

Authors:  N Bisharat; H Omari; I Lavi; R Raz
Journal:  J Infect       Date:  2001-10       Impact factor: 6.072

7.  Partial versus total splenectomy in children with hereditary spherocytosis.

Authors:  Aaron D Seims; Francine D Breckler; Kyle D Hardacker; Frederick J Rescorla
Journal:  Surgery       Date:  2013-10       Impact factor: 3.982

8.  Splenectomy in patients with sickle-cell disease.

Authors:  A H al-Salem; S Qaisaruddin; Z Nasserallah; I al Dabbous; A al Jam'a
Journal:  Am J Surg       Date:  1996-09       Impact factor: 2.565

9.  Laparoscopic splenectomy has become the gold standard in children.

Authors:  Frederick J Rescorla; Scott A Engum; Karen W West; L R Tres Scherer; Thomas M Rouse; Jay L Grosfeld
Journal:  Am Surg       Date:  2002-03       Impact factor: 0.688

10.  Partial splenectomy in children under 4 years of age with hemoglobinopathy.

Authors:  O Idowu; A Hayes-Jordan
Journal:  J Pediatr Surg       Date:  1998-08       Impact factor: 2.545

View more
  11 in total

1.  Red cell membrane disorders: structure meets function.

Authors:  Mary Risinger; Theodosia A Kalfa
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113

Review 2.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

3.  Laparoscopic Splenectomy Alone for Sickle Cell Disease: Account of 50 paediatric cases.

Authors:  Zainab N Al-Balushi; Khalid M Bhatti; Muhammad T Ehsan; Yousuf Al-Shaqsi; Nawal A R Al-Sharji; Hatem A A Mady; Mahmoud H Sherif
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

4.  Clinical and laboratory outcomes following total or partial splenectomy in patients with hereditary spherocytosis.

Authors:  Serena I Tripodi; Robert C Shamberger; Matthew M Heeney; Venée N Tubman
Journal:  Pediatr Hematol Oncol       Date:  2019-07-26       Impact factor: 1.969

Review 5.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

6.  Preventing infections in children and adults with asplenia.

Authors:  Grace M Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

7.  Diagnosis and clinical management of red cell membrane disorders.

Authors:  Theodosia A Kalfa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

8.  Recommendations regarding splenectomy in hereditary hemolytic anemias.

Authors:  Achille Iolascon; Immacolata Andolfo; Wilma Barcellini; Francesco Corcione; Loïc Garçon; Lucia De Franceschi; Claudio Pignata; Giovanna Graziadei; Dagmar Pospisilova; David C Rees; Mariane de Montalembert; Stefano Rivella; Antonella Gambale; Roberta Russo; Leticia Ribeiro; Jules Vives-Corrons; Patricia Aguilar Martinez; Antonis Kattamis; Beatrice Gulbis; Maria Domenica Cappellini; Irene Roberts; Hannah Tamary
Journal:  Haematologica       Date:  2017-05-26       Impact factor: 9.941

9.  Partial Splenectomy for a Sizeable Cavernous Hemangioma: Case Report and a Review of the Literature.

Authors:  Hatim Lazaar; Yosra Malki; Tariq Bouhout; Badr Serji; Tijani El Harroudi
Journal:  Cureus       Date:  2021-01-24

10.  Acute Splenic Sequestration Crisis in Hemoglobin SC Disease: Efficiency of Red Cell Exchange.

Authors:  Anjanaa Vijayanarayanan; Ayodeji J Omosule; Hannan Saad; Vrushali Dabak; Zaher K Otrock
Journal:  Cureus       Date:  2020-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.